- The US is pushing to tie drug prices to foreign rates, amid global trends of price controls and health technology assessments.
- Europe is exploring drug pricing proposals with the Trump administration amid pressure over drug costs and tariffs.
The administration announced new tariffs on foreign drug manufacturers, impacting the global pharmaceutical industry.
1 report, 1 independent
Updated Jun 11
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
The administration announced new tariffs on foreign drug manufacturers, impacting the global pharmaceutical industry.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- Pfizer and other companies are facing administration policy guidance regarding higher drug prices abroad in exchange for revenue sharing with HHS.Sub-event
Trump administration announces new tariffs on foreign drug manufacturers.1 source
Keep exploring
The entities involved
-
Donald Trump
American businessman and politician (born 1946), President of the United States (2017–2021; since 2025)
Related events
- AEI suggests future active engagement as Trump's tariff hook leads to fragmentation and a post-Trump US search for global influence.
- Trump sought commitments from the EU and Asia amid tariffs, coinciding with the BEA tracking foreign investment in the US.
- Trump threatens 50% tariffs on Canadian goods, escalating the trade fight and impacting North American automotive supply chains.
- Trump imposed 50% tariffs on Canadian goods, specifically targeting disputes over autos, alcohol, and dairy products.